معرفی
Dr. Wei Meng Lim is a Malaysian registered pharmacist and a Lecturer at the School of Pharmacy, Monash University Malaysia. He holds a Master of Pharmacy from the University of Strathclyde (2008), a Master of Science in Medical and Health Sciences (2014), and a PhD in Medical and Health Sciences (2019) from Universiti Perubatan Antarabangsa (International Medical University). Prior to joining academia, he worked as a pharmacist at Sarawak General Hospital (2006–2008). His research focuses on cancer biology and drug discovery, particularly targeting pancreatic and endometrial cancers through high-throughput screening, drug repurposing, and immunotherapy approaches.
Education:
- Master of Pharmacy, University of Strathclyde (2008)
- Master of Science in Medical and Health Sciences, International Medical University (2014)
- PhD in Medical and Health Sciences, International Medical University (2019)
Research Interests:
- Functional genomics and drug discovery for cancer
- Mechanisms of cancer cell survival and therapeutic targeting
- Immuno-oncology and drug combination therapies
Projects:
- Active projects include studies on gut health supplementation, compounded medication stability, and antibacterial coatings.
- Leading roles in projects like 'Identifying the Role of Soy Protein in Gut Health' and 'Improving Stability of Compounded Medications.'
Publications Trends: His recent work emphasizes nanotechnology applications in drug delivery (e.g., mesoporous silica nanoparticles, in situ gels) and molecular mechanisms in pancreatic cancer immune resistance. Themes include biomaterials for wound healing, epigenetic therapies, and natural product integration in drug formulations.
Grants and Collaborations: Active in collaborative research across Malaysia, focusing on translational medicine and biomedical innovation.
Labs/Teams: Involved in interdisciplinary teams at Monash University Malaysia, focusing on pharmacology and nanomedicine.
